|
2025
|
Invention
|
Solid state crystalline forms of a selective potassium channel modulator. The present disclosure ... |
|
2024
|
P/S
|
Printed publications, namely, brochures, newsletters, and pamphlets relating to medical issues, p... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders.. Providing health inform... |
|
|
Invention
|
Substituted aryl sulfonamides for use as sodium channel inhibitors. The present disclosure provid... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders. Providing healthcare pro... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing healthcare pr... |
|
|
Invention
|
Methods and uses for treating anhedonia.
The present disclosure is directed to, among other thin... |
|
|
Invention
|
Deuterium and aryl amine compounds and uses thereof. e.g.e.g., diseases, disorders, and condition... |
|
|
Invention
|
Benzo-fused heterocyclic compounds and uses thereof. Provided herein are compounds, including com... |
|
|
Invention
|
Heteroaryl amine compounds and uses thereof. Provided herein are compounds, including compounds o... |
|
|
Invention
|
Azepane and pyrrolidine compounds and uses thereof. e.ge.g., Formula (I)), and pharmaceutically a... |
|
|
Invention
|
Aryl amine compounds and uses thereof. Provided herein are compounds, including compounds of any ... |
|
|
Invention
|
Methods of treating depressive disorders.
In certain embodiments, the present disclosure is dire... |
|
|
Invention
|
Crystalline forms. SSS)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-5-methyl-N-(thiazol-4... |
|
|
Invention
|
Pyridine derivatives and their use as sodium channel activators.
The present disclosure is direc... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders. Providing medical inform... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing medical infor... |
|
|
Invention
|
Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opene... |
|
|
P/S
|
Pharmaceutical preparations. Providing health information to patients and healthcare
professiona... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders, namely, epilepsy, seizur... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders Providing healthcare prov... |
|
|
Invention
|
Pyridinyl derivatives as sodium channel activators.
The present disclosure is directed to compou... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders Providing health informat... |
|
|
Invention
|
Methods and uses for treating anhedonia. The present disclosure is directed to, among other thing... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders.
In certain embodiments, the present disclosure ... |
|
|
Invention
|
Methods for treating pain.
In certain embodiments, the present disclosure is directed to methods... |
|
2023
|
Invention
|
Solid state crystalline forms of a selective potassium channel modulator.
The present disclosure... |
|
|
Invention
|
Pyridinamine derivatives and their use as potassium channel modulators.
The present disclosure i... |
|
|
Invention
|
Pyridinamine derivatives and their use as potassium channel modulators. The present disclosure is... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurological disorders. Providing health inform... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurological disorders being epilepsy, focal ons... |
|
2022
|
Invention
|
Pyridinylacetamide derivatives as sodium channel activators.
The present disclosure is directed ... |
|
|
Invention
|
Pyridine derivatives and their use as sodium channel activators. The present disclosure is direct... |
|
|
Invention
|
Pyridinylacetamide derivatives as sodium channel activators. The present disclosure is directed t... |
|
|
Invention
|
Pyridinyl derivatives as sodium channel activators. The present disclosure is directed to compoun... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders. In certain embodiments, the present disclosure i... |
|
|
Invention
|
Voltage-gated potassium channel opener for use in treating anhedonia. The present disclosure is d... |
|
|
Invention
|
Conjoint therapy for treating seizure disorders. NHH-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-di... |
|
2021
|
Invention
|
Methods for treating absence seizures.
In certain embodiments, the present disclosure is directe... |
|
|
Invention
|
Flunarizine for use in treating absence seizures. The present disclosure is directed to flunarizi... |
|
|
Invention
|
Therapeutic compounds and methods of use thereof.
The invention provides a method of treating a ... |
|
|
Invention
|
Solid state forms of a selective potassium channel modulator.
The present disclosure provides so... |
|
|
Invention
|
Use of the nav1.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-... |
|
|
Invention
|
Pharmaceutical formulations for treating diseases associated with voltage-gated sodium channels. ... |
|
|
Invention
|
Use of the navi.6 sodium channel blocker (s)-4-((1-benzylpyrrolidin-3-yl)(methyl)amino)-2-fluoro-... |
|
|
Invention
|
Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents. This invention ... |
|
|
Invention
|
Substituted benzamides and methods of use thereof.
The invention provides compounds having the g... |
|
2020
|
Invention
|
Methods of treating pain.
In certain embodiments, the present disclosure is directed to methods ... |
|
|
Invention
|
Use of a kv7 potassium channel opener for treating pain. In certain embodiments, the present disc... |
|
|
Invention
|
Benzenesulfonamide compouds and their use as therapeutic agents. This invention is directed to be... |
|
2015
|
P/S
|
Development of data base systems for genetic and clinical analyses of human diseases; research an... |
|
2000
|
P/S
|
RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY |
|
|
P/S
|
RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY, NAMELY, DEVELOPING DIAGNOSTIC AND THERAPEUTIC AGENTS F... |
|
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations; diagnostic and therapeutic agents. Biotechn... |
|
|
P/S
|
BIOTECHNOLOGY RESEARCH AND DEVELOPMENT; [ DEVELOPMENT OF DATA BASE SYSTEMS FOR GENETIC AND CLINIC... |
|
|
P/S
|
Biotechnology research and development, namely, developing diagnostic and therapeutic agents for ... |
